Vaccine Cold Chain Logistics Market Research Insight 2022| Industry Development - Growth Opportunities in Future, Revenue Forecast Up to 2030

InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global Vaccine Cold Chain Logistics Market by (Services (Storage, Packaging, and Transportation), Packaging Methods (Dry Ice, Liquid Nitrogen, Gel Packs), Mode of Transportation (Ground, Air, Ocean)) - Market Outlook and Industry Analysis 2030" According to company's newest research, the global Vaccine Cold Chain Logistics Market is worth US$ 3.12 Billion in 2021 and is predicted to reach US$ 4.59 Billion in 2028, with a promising CAGR of 5.2 % between 2022 and 2028.

Get Demo Sample copy of Vaccine Cold Chain Logistics Market Report at: https://www.insightaceanalytic.com/request-sample/1127

Cold chain management has emerged as a critical aspect of maintaining vaccination safety and effectiveness as governments, businesses, and other entities initiate COVID-19 vaccine distribution operations worldwide. COVID-19 vaccines have unique cold chain needs from start to finish, from manufacturing through distribution to warehouses and healthcare facilities. A practical and resilient vaccine supply chain, aided by temperature monitoring systems, is required to maintain production, minimize loss, and ensure vaccinations reach target populations. To preserve the integrity of COVID-19 vaccines, a cold and ultra-cold pharmaceutical supply chain combining thermal and refrigerated packing technologies and logistical planning is required. Cold chain management requires ensuring that highly temperature-sensitive coronavirus vaccines are kept at the proper temperature throughout the manufacturing, storage, shipping, and distribution operations.

Market Dynamics:

Due to a rise in refrigerated warehouses, expansion in the pharmaceutical sector, and rising demand for mRNA-based vaccines, the global Cold Chain Logistics Market has seen considerable growth. Increased demand for effective cold chain logistics services to ensure product quality and increased demand for infectious disease vaccines are likely to drive market expansion over the forecast period. Furthermore, rising healthcare spending and increased R&D investments to create vaccine storage facilities are expected to boost the market growth.

The COVID-19 pandemic has shown a considerable increase in demand for vaccine storage services, prompting pharmaceutical companies to invest in cold chain logistics. As a result, increased R&D initiatives are expected to provide new growth prospects for the vaccine cold chain logistics market in the coming years.

A surge in government initiatives for logistics infrastructure and an increase in the demand for cold chain storage systems in North America is expected to drive the vaccine cold chain logistics market in 2021. In the pharmaceutical industry, quality and product sensitivity are the essential considerations in the region. Due to expanding R&D investments in pharmaceutical sector advances, rising vaccination demand, and well-developed healthcare infrastructures, Asia Pacific is expected to grow considerably over the projection period (2022-2030).

For more Customization in this Report, Connect with us at: https://www.insightaceanalytic.com/customisation/1127

Key Developments:
• In Aug 2021, Yusen Logistics Co., Ltd. was in control of the worldwide transportation of AstraZeneca Co., Ltd.'s COVID-19 vaccine from Japan to Taiwan, Vietnam, Indonesia, Thailand, the Philippines, and Malaysia, as arranged by the Japanese government. Furthermore, the company is extending its operation bases in each country following GDP, with the goal of creating a network of high-quality pharmaceutical logistics services that satisfy consistent standards and ensure product integrity. At present, 39 operation sites in 24 nations and regions throughout the world comply with our worldwide GDP standards.
• In Aug 2021, Cryoport announced a multi-year strategic alliance with Mitsubishi Logistics Corporation of Japan (MLC). The "strategic alliance" will offer complete, end-to-end distribution solutions for specialist cell and gene therapies that require strict temperature control, track and trace systems, and global distribution.
• In May 2021, DB Schenker Americas added a new 5,000-square-foot cold room and 50,000-square-foot controlled room temperature space to its existing Indianapolis logistics centre. The new facility is expected to meet the increased need for temperature-controlled logistics space in the pharmaceutical industry. By constructing the extensions in Indianapolis, DB Schenker will be able to take advantage of a less congested American airport to travel directly to and from Luxembourg using its own-controlled planes.

The following key companies are engaged in the Vaccine Cold Chain Logistics market:
Cryoport (U.S.), DHL Express (Germany), GAC (Dubai), Lynden International Logistics (Canada), PAREXEL (U.S.), United Parcel Service (UPS Healthcare U.S.), DB Schenker (Germany), Yusen Logistics (U.S.), CEVA Logistics, Q1 Scientific, Marken Ltd., AmeriCold Logistics LLC, FedEx Corporation, Yamato Logistics, and Other Prominent Players.

Get Extra Discount on Vaccine Cold Chain Logistics Market Report, if your Company is Listed in Above Key Players List @ https://www.insightaceanalytic.com/enquiry-before-buying/1127

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.